Blisters and skin fragility on the back of the hands is typical.
Porphyria Cutanea Tarda (PCT) is a blistering disease, most common on the back of the hands caused by sun exposure and build up in the blood of porphyrins.
Vesicles, milia, erosions and fragile skin occur symmetrically on the dorsa of the hands in porphyria cutanea tarda. Look for hypertrichosis along the forehead. In rare cases, usually when the disease goes for a long time untreated, indurated, sclerodermoid plaques may develop on the trunk. The hematocrit is often elevated.
Diagnosis is made by measuring urinary porphyrins and excluding VP through measurement of fecal porphyrins. PCT may develop in the setting of renal failure and dialysis. Finally, a bullous dermatosis mimicking PCT (pseudoporphyria) but without elevated porphyrin levels may also occur in dialysis patients. This type may be related to various drugs (e.g. furosemide, nalidixic acid and tetracycline).
So, to clarify, a drug may cause PCT which on workup would show elevated porphyrins. Or, a drug could cause pseudopct which would not show elevated porphyrins. But the clinical picture (e.g. blisters and vesicles on the back of the hands) is the same.
DIF shows fluorescence of thickened doughnut-like blood vessels in the upper dermis, reflecting deposition of immunoglobulins and C3, and deposition of immunoglobulins or C3 or both at the dermal-epidermal junction in most cases.
Elimination of any cause/trigger if present (e.g. alcohol, BCP, drug) is important.
Sun protection is key. The action spectrum appears to be primarily in the UVA range so sunscreens with UVA blockage are mandatory. Those often include the metal-containing sunscreens. Some have theorized that even the visible spectrum plays a role. The damage to the skin occurs over months and thus repair will occur over a similar timeframe.
Hydroxychloroquine 100 mg po twice weekly is an excellent treatment option and may be first line. It should be avoided in patients with hepatic or renal dysfunction. Time to remission is about 6 months.
Phlebotomy has been the primary treatment for years, but is expensive, somewhat inconvenient and has the risk of inducing anemia or syncope. A unit of blood is removed every 2-4 weeks to decrease the hematocrit. The CBC should be followed and phlebotomy withheld if the hemoglobin level is < 10 g/dL or the hematocrit level < 33.
For the PCT of renal failure and dialysis, erythropoietin and phlebotomy, deferoxiamine or renal transplantation have been used.
Who is Dr. White? | Privacy Policy | FAQs | Use of Images | Contact Dr. White